FDA Approved: EMRELIS — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved EMRELIS (telisotuzumab vedotin) under the original application submitted by AbbVie. The approval pertains to a MET-targeted antibody-drug conjugate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EMRELIS (Telisotuzumab vedotin)

Snippet

ORIG AP for EMRELIS (TELISOTUZUMAB VEDOTIN)